drugset / Trial / NCT01219751
Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
Phase 2
Unknown
35 enrolled
Asan Medical Center
Kyungpook National University Hospital · collabSamsung Medical Center · collabSeoul National University Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of sunitinib in non-clear cell type renal cell carcinoma with the exception of pure sarcomatoid carcinoma and collecting duct carcinoma
Timeline
- Start
- 2008-06
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | 50 mg | Oral |